Cochrane COVID-19 Study Register
Study record
NCT05074121First Published: 2021 Oct 12Updated Date: 2021 Oct 12

N-acetylcysteine for Attenuation of COVID Symptomatology

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
Reference record

NAC for Attenuation of COVID Symptomatology

Cambridge Health Alliance
First Published (first received 2021 October 12)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05074121)
Trial registry record
No Results
The objective of this study is to determine whether oral NAC is effective at attenuating COVID-19 disease symptom severity and duration of symptoms